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OBJECTIVES The study was done to determine whether the effects of parasympathetic withdrawal on heart
rate, blood pressure (BP), and systolic and diastolic function are altered with normal aging.
BACKGROUND Cardiac responses to beta-adrenergic sympathetic stimulation decline with aging as does the
heart rate response to parasympathetic withdrawal, but the extent to which other responses to
parasympathetic withdrawal decrease is less clear.
METHODS Heart rate, BP, systolic function, and diastolic filling responses to parasympathetic with-
drawal induced by atropine (0.02 mg/kg) were compared in 50 healthy subjects, 28 older (ages
65 to 80 years, mean 70 years; 18 females all on estrogen) and 22 young (age 18 to 32 years,
mean 26 years; 12 females) subjects, using radionuclide angiography.
RESULTS Parasympathetic withdrawal in the older group caused less of an increase in heart rate (33
vs. 48 beats/min), cardiac index (0.6 vs. 1.5 l/m2), systolic blood pressure (1 vs. 7
mm Hg), and early diastolic filling rate (1.7 vs. 2.4 end-diastolic volumes/s) (all p 
0.01). At similar declines in the diastolic filling period, end-diastolic volume index (EDVI)
fell substantially more in the older group (11.6 vs. 2.4 ml/m2, p  0.001). The only
gender difference was in diastolic filling rate, which was similar in the young males and
females, but significantly less in older males than in older females.
CONCLUSIONS The responses to parasympathetic withdrawal as well as sympathetic stimulation decline with
aging, and both contribute to the reduced cardiovascular responses to stress with advancing
age. (J Am Coll Cardiol 2003;41:2077–83) © 2003 by the American College of Cardiology
Foundation
The marked increase in cardiac output during exercise or
other stress depends on increases in heart rate and stroke
volume. Increased beta-adrenergic stimulation and with-
drawal of parasympathetic tone largely govern these
changes. With aging, in the absence of disease, sympathetic
control of the heart declines; this is manifested by reduced
heart rate, blood pressure (BP), ejection fraction (EF), and
cardiac output responses to beta-adrenergic stimulation
(1,2). Although the heart rate response is known to decline
with aging (3,4), little is known about the impact of aging
on other cardiovascular responses to parasympathetic with-
drawal.
Parasympathetic control of cardiovascular function in-
cludes marked effects on heart rate and the conduction
system and lesser effects on atrial and ventricular contrac-
tility. Vagal activity inhibits the sinoatrial node, atrial
myocardium, and atrioventricular conduction tissue and also
depresses ventricular myocardium (5–9). There is conflict-
ing evidence about whether parasympathetic control of
cardiac function changes with age. In rat models, evidence
with aging shows both an increased and reduced sensitivity
to vagal activity (10–12). In humans, evidence of an
age-related decrease in parasympathetic modulation in-
cludes studies of heart rate variability (HRV) and baroreflex
sensitivity, which decline with aging (3,13–19). There is a
reduced heart rate response to parasympathetic withdrawal
with aging (3,4), but whether contractility or diastolic filling
responses are altered is unknown. A recent study suggested
important age-related differences in BP control due to age
differences in vagal inhibition of heart rate and thereby
cardiac output (20). In addition, whether gender influences
parasympathetic control of cardiovascular function is un-
known.
In the current study, vagal blockade induced by atropine
was used to investigate age differences in cardiac parasym-
pathetic regulation. The purpose of this study was to
determine the influence of aging on contractile, BP, and
diastolic filling responses to parasympathetic withdrawal.
We hypothesized that aging would be associated with lesser
changes in systolic and diastolic measures with parasympa-
thetic withdrawal due to a lower baseline vagal tone. We
also sought to determine whether gender differences exist in
the effects of parasympathetic withdrawal. Our results doc-
ument that normal aging in the absence of disease is
associated with lesser parasympathetic regulation of heart
rate, cardiac output, and diastolic filling.
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METHODS
Subject selection. Healthy males and females age 18 to 33
or 65 to 80 years who were sedentary (no regular exercise
20 min 2 times weekly) were screened. Exclusion
criteria included current smoking, hypertension, any cardio-
vascular disease, exercise-limiting arthritis or pulmonary
disease, obesity (body mass index  30), and chronic use of
any prescription medication except for treated hypothyroid-
ism (n  2) and estrogen replacement therapy, which all
older females received. Inclusion criteria were an unremark-
able medical history, physical examination, blood tests
(complete blood count, sodium, potassium, chloride, bicar-
bonate, blood urea nitrogen, creatinine, albumin, serum
glutamic-oxaloacetic transaminase, alkaline phosphatase,
lactic dehydrogenase, cholesterol, thyroid stimulating hor-
mone), urinalysis, urine pregnancy test (young females),
normal echocardiogram (no more than mild regurgitation),
and normal Bruce protocol maximal exercise testing, which
included normal postexercise single-photon emission com-
puted tomography technetium-99m sestamibi imaging in all
older subjects. Twenty-eight older (mean  70 years, range
65 to 80 years, 18 females and 10 males) and 22 younger
(mean age  26 years, range 18 to 32 years, 13 females and
9 males) healthy volunteers were studied. The study was
approved by the Human Subjects Committee of the Uni-
versity of Washington. Procedures followed were in accor-
dance with institutional guidelines. All subjects gave in-
formed written consent.
Study protocol. Following placement of intravenous cath-
eters, subjects rested supine for 30 min. Two bolus intrave-
nous injections of atropine were administered for a total of
0.02 mg/kg (0.01 mg/kg initially and repeated in 6 min).
Cardiac blood pool images, heart rate, and BP were re-
corded at rest and beginning 3 min after each atropine
injection.
Data collection and processing. RADIONUCLIDE ANGIOG-
RAPHY. Red blood cells were labeled with Tc-99m and
images acquired in the left anterior oblique projection,
which offered the best septal definition with a high sensi-
tivity parallel hole collimator, 32 frames, and a 20%
arrhythmia rejection. The resting acquisition was for 15
million counts and subsequent acquisitions were for 3 min.
The EF and cardiac volumes were calculated using modifi-
cations of previously described and validated methods (21).
Image data were excluded in two subjects (both young
females) because of poor image quality due to a poor red
blood cell tag. Volumes were divided by the body surface
area to derive end-diastolic volume index (EDVI), end-
systolic volume index (ESVI), and stroke volume index
(SVI). Cardiac index (CI) was obtained by multiplying the
SVI times the mean heart rate during the acquisition. The
peak early filling rate (PEFR) was measured as previously
described (22) and expressed in both ml/s/m2 and in
EDV/s. The diastolic filling time was calculated by sub-
tracting the systolic emptying period in ms from the RR
interval.
HRV. Two-channel Holter recordings were obtained in 10
older and 14 younger subjects to document that the atropine
doses used caused parasympathetic withdrawal as measured
by HRV. Tapes were analyzed with a Spacelabs Model
FT2000 (Issaquah, Washington). Two minutes of recording
were performed at rest and during the radionuclide angio-
grams. The root-mean square of difference of successive RR
intervals (RMSSD) was used as the measure of HRV.
Statistical analysis. Results are expressed as the mean 
SE. The effects of age and gender were compared using
analysis of variance for repeated measures, which included
rest data and data after each atropine dose (StatView 5.0,
Abacus, Berkeley, California). The reported p values are for
the effects of atropine and the interaction term (old vs.
young  atropine or males vs. females  atropine). An
unpaired t test was used to compare the percentage change
from rest to the final atropine dose between groups. Statis-
tical significance was established at p  0.05.
RESULTS
Effects of aging on heart rate and cardiac systolic func-
tion responses. Heart rate increased significantly less in the
old than in the young (52% vs. 74%, p  0.0001) (Fig. 1,
Table 1). Parasympathetic withdrawal in these resting
subjects caused no change in EF. The EDVI, ESVI, and
SVI fell significantly in both groups, but there was no
difference between age groups. Because of the lesser increase
in heart rate in the older subjects and the somewhat greater
decline in SVI, the CI increased less in the older group (22%
vs. 53%, p  0.0001). The CI increased by 0.6 l/min/m2 in
the older group compared to 1.5 l/min/m2 in the young.
Systolic and mean BP increased less in the old than in the
young (both p  0.001). The diastolic BP response was not
different between the two groups.
Effects of aging on diastolic filling and end-diastolic
volume (EDV) responses. Parasympathetic withdrawal in-
creased diastolic filling rates significantly (p  0.0001).
However, the increase in diastolic filling rates with para-
sympathetic withdrawal was attenuated with aging (Table
2). The mean PEFR in ml/s/m2 increased by 64 in the old
compared with 120 in the young, and the mean PEFR in
Abbreviations and Acronyms
BP  blood pressure
CI  cardiac index
EDV  end-diastolic volume
EDVI  end-diastolic volume index
EF  ejection fraction
ESVI  end-systolic volume index
HRV  heart rate variability
PEFR  peak early filling rate
RMSSD  root-mean square of difference of successive
RR intervals
SVI  stroke volume index
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EDV/s increased 1.7 in the older group compared with 2.4
in the young (both p  0.04 age group  dose).
The EDVI was more adversely affected by tachycardia in
the older group (Fig. 2). To assess changes in diastolic
volume at similar decrements in diastolic filling time, we
compared the results in the older group after the second
atropine dose, when the heart rate had increased to 94
beats/min, to the results in the younger group after the first
atropine dose when subjects’ heart rate had increased sim-
ilarly to 96 beats/min. The diastolic filling periods were
similar in the old and young at these heart rates (340  13
ms old vs. 349  15 ms young, p  ns). At these similar
heart rates and diastolic filling periods, the fall in EDVI in
the older group was nearly fivefold greater than in the young
(11.6  1.6 ml/m2 vs. 2.4  1.6 ml/m2, p  0.04).
Thus, tachycardia impaired ventricular filling more with
aging as measured by peak early filling rates and by the
decline in EDVI at similar decrements in the diastolic filling
period.
Gender effects. No gender differences existed in heart rate,
BP, EF, EDVI, ESVI, SVI, or CI responses to parasym-
pathetic withdrawal. Although parasympathetic withdrawal
increased diastolic filling rates in both genders, the increase
was less in males than in females as measured in either
EDV/s or ml/s/m2 (both p  0.05 for gender  dose)
(Table 2). This gender difference was largely due to a
difference in the older men compared with older women,
because the younger men and women had similar responses
(Table 2, Fig. 3).
HRV. The HRV as measured by the RMSSD declined
with atropine (p  0.0001). The response to atropine was
less in the old (26  7 at rest to 11  3 ms after the first
dose to 18  9 ms after the second dose) than in the young
(53  8 to 10  2 to 8  0.2 ms) (p  0.002), owing to a
substantially lower resting HRV in the older group. No
gender difference existed in the HRV response.
DISCUSSION
This study investigated differences in heart rate, systolic,
and diastolic responses to parasympathetic withdrawal as a
function of aging. Aging reduced the effects of parasympa-
thetic withdrawal on heart rate, CI, systolic BP, mean BP,
and diastolic filling. These results document that parasym-
pathetic modulation of cardiovascular function is influenced
by normal aging. Mechanisms underlying the reduced
cardiac vagal control with aging could occur at several levels.
In humans, M2 muscarinic receptor density is reduced with
aging, and there is decreased receptor function (4). Musca-
rinic receptor activity is probably reduced with aging (23),
and impaired cardiac acetylcholine release occurs in re-
sponse to stimulation (24). Whether human acetylcholines-
terase levels change with aging is not clear.
Aging differences. HEART RATE AND CI. This study and
prior studies document that the resting heart rate is under
less parasympathetic control with advancing age (3,4). The
likely major underlying factor in the reduced response to
parasympathetic withdrawal with aging is the age-associated
reduction in baseline parasympathetic activity. Parasympa-
thetic modulation of heart rate as estimated by the barore-
flex response (25) or HRV (13,16,26) decreases with aging.
Fukusaki et al. (15) concluded that the age-related decline
in HRV was primarily mediated by aging per se and not by
physiologic changes of normal aging such as fitness, body
habitus, obesity, or BP. In the current study, older subjects
had reduced HRV at rest, and a lesser change in HRV with
atropine. The reduced cardiac output response to parasym-
pathetic withdrawal with aging is almost entirely due to the
lesser increase in heart rate, as stroke volume responses do
not change significantly with age.
CONTRACTILITY AND BP. Although vagal activity has been
shown to inhibit contractile function at rest in animal
models and in isolated human right atrial strips (27), vagal
inhibition of ventricular contractility in humans has only
been demonstrated under conditions of increased sympa-
thetic stimulation (5,28,29). Earlier studies have docu-
mented a moderately increased sympathetic tone with aging
(30). Despite this, we found no age difference in ventricular
contractile responses to parasympathetic withdrawal with
Figure 1. Heart rate (A) and cardiac index (B) ( SEM) in the young (Y)
and older (O) groups at rest and following atropine (p  0.0001 for old vs.
young  atropine dose).
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aging. Thus, the current study supports the conclusion that
vagal activity has minor, if any, effects on ventricular
contractility in resting humans who have low basal levels of
sympathetic tone.
Differences in baseline vagal activity with age appear
important in BP control. Older men had a greater decline
than young men in mean BP (40% vs. 20%) following
ganglionic blockade (20). The greater reduction was due to
a lesser increase in cardiac output, which in turn was due to
a lower increase in heart rate (3 vs.25 beats/min), which
appeared due to a reduced basal tonic vagal control. Our
findings of lesser changes in systolic and mean BP and heart
rate and cardiac output with atropine in older subjects are
concordant.
DIASTOLIC FILLING. The large increases in diastolic filling
rates that occur during exercise depend on the ability of the
ventricle to relax quickly and completely (31). Increased
sympathetic activity increases diastolic filling (32,33), but
there is less information regarding parasympathetic influ-
Table 1. Mean Responses to Atropine (Mean  SE) in Young and Older Subjects
Rest 0.01 mg/kg 0.02 mg/kg
ANOVA p Values
Mean % Change






Young 65  1 96  2 113  2 0.0001 0.0001 74  4
Older 61  1 86  2 94  2 52  4*
Systolic BP (mm Hg)
Young 119  2 124  3 126  3 0.008 0.001 6  1
Older 129  3 129  3 128  2 1  1*
Diastolic BP (mm Hg)
Young 73  1 78  1 77  2 0.0001 NS 9  2
Older 73  1 78  2 80  2 6  2
Mean BP (mm Hg)
Young 88  1 93  2 95  2 0.0001 0.02 8  1
Older 92  2 95  2 94  2 2  2*
EF
Young 65  2 65  2 64  2 NS NS 3  1
Older 61  2 61  2 60  2 1  2
EDVI (ml/m2)
Young 68  4 66  4 60  4 0.0001 NS 11  4
Older 65  3 56  4 53  3 15  3
ESVI (ml/m2)
Young 24  2 23  2 22  2 0.0001 NS 6  5
Older 25  2 22  2 21  2 16  3
SVI (ml/m2)
Young 44  3 43  3 39  3 0.0001 NS 13  4
Older 39  2 35  3 32  2 19  3
CI (l/m2)
Young 2.9  0.2 4.1  0.3 4.4  0.4 0.0001 0.0002 53  9
Older 2.4  0.1 3.0  0.2 3.0  0.2 22  4*
*p  0.01 for old vs. young on % change with atropine.
ANOVA  analysis of variance; BP  blood pressure; CI  cardiac index; EDVI  end-diastolic volume index; EF  ejection fraction; ESVI  end-systolic volume index;
SVI  stroke volume index.
Table 2. Diastolic Filling Responses to Atropine by Age and Gender




Young vs. Old 
Atropine Dose
Female vs. Male 
Atropine Dose
PEFR index in ml/s/m2 0.0001 0.04 0.04
Young female 255  14 340  17 390  37
Young male 213  28 268  40 309  49
Older female 163  9 246  28 251  23
Older male 129  21 140  21 149  28
PEFR in EDV/s 0.0001 0.02 0.05
Young female 3.6  0.2 5.1  0.2 6.1  0.4
Young male 3.3  0.1 4.3  0.3 5.6  0.6
Older female 2.6  0.1 4.2  0.4 4.7  0.3
Older male 2.0  0.2 2.7  0.2 2.9  0.4
ANOVA  analysis of variance; EDV  end-diastolic volume; PEFR  peak early filling rate.
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ence. In one study, both increases and decreases in vagal
activity had no effect on tau, the time constant of left
ventricular isovolumic pressure decay (29); however, a neg-
ative lusitropic effect of parasympathetic activity was de-
monstrable during concomitant increased sympathetic tone.
In contrast, in animals there was no evidence of vagal
influence on tau or chamber stiffness constant (6) in one
study, but a clear decrease of tau with vagal stimulation in a
different study (34); this same study (34) found that vagal
stimulation in animals had a greater effect on tau than on
contractile measures. Our findings are in accord in that we
found no effect of vagal withdrawal on EF but a marked
effect on diastolic filling. Our measure of diastolic filling is
not analogous to tau, in that PEFR occurs somewhat later in
early diastole than does tau, which occurs during isovolumic
diastole.
The final phase of diastolic filling is due to atrial
contraction, and atrial contraction is decreased by vagal
activity (8,9). In one Doppler echocardiographic study,
measures of HRV correlated inversely with A-wave velocity
(35), raising the possibility that reduced parasympathetic
tone with aging may account in part for the increase in
A-wave velocity that occurs with aging. In another study
(36), atropine caused lesser increases in Doppler
echocardiography-measured A-wave peak in older subjects
(p 0.02), consistent with a lower baseline vagal activity. In
the current study, parasympathetic withdrawal caused lesser
increases in early diastolic filling rates in the older group.
However, the PEFR that we measured occurs early in
diastole and is unlikely to have been influenced by differ-
ences in atrial contraction.
Tachycardia induced by parasympathetic withdrawal
shortens the cardiac cycle largely at the expense of diastole.
In a prior study (37), similar atropine doses shortened the
RR interval by 378 ms, of which 351 ms was due to
shortening in diastolic filling time. The marked shortening
of diastole with parasympathetic withdrawal is the probable
cause of the drop in EDVI that occurred in both age groups.
However, the older and probably stiffer ventricles were
particularly vulnerable to shortening of diastole, having
much greater declines in EDVI at a similar decrement in
filling time. Thus, the older ventricle is less able to adapt to
the demands of a tachycardia. The physiologic importance
of the decline in parasympathetic withdrawal responses with
aging is suggested by the correlation between the increase in
heart rate following atropine and the peak heart rate
achieved during maximal exercise testing in these same
subjects (r  0.79, p  0.0001). Taken together, these
Figure 2. The decline in end-diastolic volume index following atropine at
similar heart rates (94  2 old vs. 96  2 young, p  ns) and diastolic
filling periods (340 13 ms old vs. 349 15 ms young, p ns) was nearly
fivefold greater in the old than in the young (11.6  1.6 ml/m2 old vs.
2.4  1.6 ml/m2 young, p  0.04).
Figure 3. Change in peak early diastolic filling in ml/s/m2 (A) and in
end-diastolic volume (EDV)/s (B) in young males (YM) and older males
(OM) and young females (YF) and older females (OF) (both p  0.01 for
young vs. old  dose and p  0.02 for male vs. female  dose).
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studies help establish the importance of changes in vagal
tone on cardiovascular regulation with aging.
Gender differences. Few gender differences were seen.
Resting PEFR in EDV/s was greater in the older females
(all on hormone replacement) than in males (2.6 vs. 2.0
EDV/s), similar to a study by Spina et al. (2.4 vs. 2.0
EDV/s) in which hormone replacement status was not
stated (38). We also found that older females had more
preserved (i.e., greater) diastolic filling responses to para-
sympathetic withdrawal. The differences in filling rates in
the older women and older men cannot be explained by
factors known to directly or indirectly influence filling such
as heart rate, EF, EDVI, or BP, which were similar in our
study. In one prior study (39), estrogen replacement im-
proved resting diastolic filling measured by echocardiogra-
phy, and estrogen replacement improved endothelial func-
tion (40,41). Thus, it is possible that estrogen replacement
influenced our results.
Study limitations. The observed hemodynamic changes
represent both the primary effects of parasympathetic with-
drawal and secondary reflex responses. The relative contri-
butions cannot be determined. In addition, we cannot
determine whether differences noted in diastolic filling with
aging were simply consequent to tachycardia in a stiffer
ventricle or were due to the elimination by atropine of a
baseline parasympathetic lusitropic effect. This study is also
unable to differentiate with certainty whether differences in
responsiveness were due to a difference in vagal input to the
heart or reduced tissue responsiveness. A weight-based
atropine dose was given, and subjects received up to 2 mg,
but we did not document complete blockade by giving an
even higher dose.
The greater increase in systolic and mean BP in the young
may have resulted in a greater decrease in the young in
cardiac sympathetic activity due to the baroreflex. However,
if this occurred, it would tend to lessen, not exaggerate, the
observed age differences in heart rate and diastolic filling. In
addition, in a prior study (37) we found no atropine effect on
plasma catecholamines, thereby suggesting no atropine ef-
fect on sympathetic activity. Because all older females were
receiving hormone replacement therapy, our results cannot
be generalized to all older women.
Significance of the study findings. This study extends our
understanding of the importance of changes in autonomic
nervous system regulation of cardiac function with aging.
The rigorous screening criteria make it unlikely that the
observed differences are due to occult disease in the older
group. Rather, the changes seen are more likely primary
age-associated differences. This investigation demonstrates
that the aging cardiovascular system is under lesser vagal
control, and this is manifested by differences in heart rate,
BP, and cardiac output responses to parasympathetic with-
drawal. This in turn is likely primarily due to a reduction in
baseline vagal tone. Additionally, diastolic filling responses
decline substantially with age, particularly in men, with the
older ventricle having lesser increases in diastolic filling rates
and greater declines in EDV with an increase in heart rate.
These changes likely contribute to the greater prevalence of
diastolic heart failure with aging, and they point to a
potential mechanism underlying diastolic dysfunction in the
elderly. Overall, these findings suggest a substantial decline
in parasympathetic regulation of cardiac function with
aging. Thus, cardiac responses to both sympathetic stimu-
lation and to vagal withdrawal are attenuated with normal
aging.
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